When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. TCH (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/TCH_(chemotherapy)

   TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer. References

3. Triple-negative breast cancer - Wikipedia

   en.wikipedia.org/wiki/Triple-negative_breast_cancer

   Triple-negative is sometimes used as a surrogate term for basal-like. [2] Triple-negative breast cancer comprises 15–20% of all breast cancer cases [3] and affects more young women or women with a mutation in the BRCA1 gene than other breast cancers. [4] Triple-negative breast cancers comprise a very heterogeneous group of cancers.

4. Combination therapy shows promise against triple-negative ...

   www.aol.com/combination-therapy-shows-promise...

   Breast cancer is the most common cancer in women worldwide, and can, rarely, also occur in men. There are many different types of breast cancer, of which triple-negative breast cancer is one of ...

5. Chemotherapy regimen - Wikipedia

   en.wikipedia.org/wiki/Chemotherapy_regimen

   breast cancer ("TAC" can also refer to tetracaine-adrenaline-cocaine, used as local anesthetic) TAD tioguanine, cytarabine (ara-C), daunorubicin: acute myeloid leukemia: TC or CT docetaxel (Taxotere), cyclophosphamide: breast cancer: TCH: docetaxel (Taxotere), carboplatin, trastuzumab (Herceptin) breast cancer with positive HER2/neu receptor TCHP

6. AstraZeneca's breast cancer drug combination fails in late ...

   www.aol.com/news/astrazenecas-breast-cancer-drug...

   The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients with inoperable or metastatic triple-negative breast cancer versus the older and ...

7. Platinum-based antineoplastic - Wikipedia

   en.wikipedia.org/wiki/Platinum-based_antineoplastic

   In this form of chemotherapy, commonly used drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development. [1] Addition of platinum-based chemotherapy drugs to chemoradiation in women with early cervical cancer seems to improve survival and reduce risk of recurrence. [2]